Immunocore announces transition of Chief Financial Officer - Immunocore Hldgs ( NASDAQ:IMCR )
( OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 29 August 2024 ) Immunocore Holdings plc IMCR ( "Immunocore" or the "Company" ) , a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for ...
| Ticker |
Sentiment |
Impact |
|
IMCR
|
Somewhat Bullish
|
38 %
|
|
BMY
|
Neutral
|
4 %
|
